Blake Borgeson, Director of Recursion Pharmaceuticals RXRX, has filed 0 purchases and 58 sales on the open market. Over the past 12 months that comes to a net sale of $3.7M. The latest trade was on 06/17.

BB

BB

Blake Borgeson

Director

Company

Recursion Pharmaceuticals RXRX

First filing

23/01/05

Trades

70 trades

Buys / sales

0 / 58

12-month net buying

−$3.7M

Last trade

06/17

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	06/02	06/04	30,000 sh	$3.68	$110,400	−0.5%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	05/05	05/07	30,000 sh	$3.52	$105,600	−0.5%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	04/07	04/08	30,000 sh	$3.10	$93,000	−0.5%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	03/03	03/04	170,000 sh	$3.46	$588,200	−2.6%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	02/03	02/06	220,000 sh	$4.20	$924,000	−3.3%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	01/06	01/08	220,000 sh	$4.36	$959,200	−3.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	25/12/02	25/12/04	220,000 sh	$4.37	$961,400	−3.1%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/11/12	24/11/14	11,447 sh	$7.64	$87,455.08	−0.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/10/29	24/10/31	11,447 sh	$6.72	$76,923.84	−0.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/10/15	24/10/17	11,447 sh	$6.67	$76,351.49	−0.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/10/01	24/10/03	11,447 sh	$6.22	$71,200.34	−0.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/09/17	24/09/19	11,447 sh	$6.84	$78,297.48	−0.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/09/03	24/09/05	11,447 sh	$6.27	$71,772.69	−0.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/08/20	24/08/22	11,447 sh	$7.12	$81,502.64	−0.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/08/06	24/08/08	11,447 sh	$6.82	$78,068.54	−0.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/07/23	24/07/25	11,447 sh	$8.48	$97,070.56	−0.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/07/09	24/07/11	11,447 sh	$7.32	$83,792.04	−0.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/06/25	24/06/27	11,447 sh	$9.51	$108,860.97	−0.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/06/11	24/06/13	11,447 sh	$8.45	$96,727.15	−0.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/05/28	24/05/30	11,447 sh	$9.17	$104,968.99	−0.2%